Professor Glenda Gray is a scientist working around the clock to stem the impact of HIV-Aids in the country. Gray is a senior ...
GlobalData on MSN
Trials to watch: Phase III TB vaccines and MDR-TB treatments
GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.
Ohioans who remember measles and polio are fighting vaccine hesitancy as school immunization rates decline. Judith Feinberg ...
Recognised for using genomics to help guide a mass typhoid vaccine rollout that has already reached more than 40 million children ...
The HIV prevention shot lenacapavir will be rolled out at South African clinics within the next few months – from 2027, the ...
Indonesia has intensified its nationwide campaign against tuberculosis (TB) on World TB Day, unveiling a series of measures aimed at reducing infections, improving detection, and achieving its target ...
In this special briefing, Spotlight unpacks what we do and do not know about asymptomatic TB. Tuberculosis (TB) is a ...
GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets where the biology has already been de-risked. The question is whether this ...
A groundbreaking new drug to prevent HIV infection – the closest the world has to a vaccine – is being rolled out in some of ...
Gilead has handed back a next-gen hepatitis B antiviral to Assembly Biosciences, while the two companies continue to partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results